Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Oligomerix Appoints Cara Cassino As Interim President and CEO
PRIVATEAug 31, 2026•6 days ago
Position
Chief Executive Officer
Company
Oligomerix
Cara Cassino
White PlainsHealthcare
Description
Oligomerix has appointed Dr. Cara Cassino as Interim President and Chief Executive Officer. This strategic appointment aims to leverage her experience in the biopharmaceutical industry.
Company Information
Company
Oligomerix
Location
2 WESTCHESTER PARK DRIVE
White Plains, New York, United States
About
Oligomerix is an emerging biotechnology company focused on developing disease-modifying therapeutics for neurodegenerative diseases characterized by aberrant tau protein ranging from rare tauopathies such as progressive supranuclear palsy and frontotemporal dementia to Alzheimer’s disease. With a focus on oral, small molecule, tau self-association inhibitors, Oligomerix seeks to develop therapies for Alzheimer’s disease and other dementias that are easy to administer and cost effective, and which are expected to significantly add to newly emerging high-cost therapeutic options such as the monoclonal antibody targeted against beta-amyloid that was recently approved by the U.S. FDA.
Don't miss Oligomerix's next move
Get an email the moment Oligomerix changes its leadership, hires an exec, or expands, usually minutes after it happens.
White PlainsHealthcare